LNAI Lunai Bioworks Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q May 15, 2026
$1.30
· of 52w range
· above low
· to high
$0.1552w low
$5.0252w high
Market Cap (MRQ)
$47M
P/E
-0.1
EPS
$-1.08
your badges
52W Range
$0–$5
Analyst Rating
·
Price Target
·
P/E
-0.1
ROE
-586.4%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
LNAI Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.30
Market Cap (MRQ)
$47M
P/E
-0.1
EPS
$-1.08
ROE
-586.4%
52W Range
$0–$5
LNAI Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| May 22, 2026 | 1-for-8 | Reverse |
| Sept. 30, 2025 | 1-for-10 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-1.082022-06-30 → 2025-06-30
Free Cash Flow·2022-06-30 → 2024-06-30
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | LNAI | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -0.15Y avg ≈-9.7 | ≈-9.7 | · | · | |
| P/B (MRQ) | -4.9 | · | · | · | |
| Price / Cash Flow | -2.9 | · | · | · | |
| Price / Tangible Book (MRQ) | -4.85Y avg ≈14.4 | ≈14.4 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | LNAI | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -207.8% | · | -134.9% | Weak | |
| ROE | -586.4% | · | -304.7% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | LNAI | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 0.2 | · | 2.1 | Low liquidity | |
| Quick Ratio | 0.0 | · | 1.4 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Next Report
Nov 12, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | $-0.08 | — | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $537.4K | $3M | $4M | $8M | $16M | $5M | $2M | $617.0K | $62.8K | |
| SG&A Expense | $18M | $25M | $15M | $14M | $8M | $7M | $8M | $4M | $933.8K | |
| Operating Expenses | $189M | $82M | $39M | $116M | $23M | $12M | $11M | $5M | $2M | |
| Operating Income | $-189M | $-82M | $-39M | $-116M | $-23M | $-12M | $-11M | $-5M | $-2M | |
| Interest Expense | · | · | · | $372.8K | $379.6K | $104.3K | $43 | $143.3K | · | |
| Interest Income | · | · | · | $122.0K | $13.2K | $50.3K | $73.5K | $45.8K | · | |
| Other Non-op | $11M | $-7M | $-1M | $3M | $-3M | $507.4K | $-7M | $-1M | $192.7K | |
| Pretax Income | · | · | $-40M | $-113M | $-27M | $-11M | $-18M | $-6M | $-2M | |
| Income Tax | $1.5K | $0 | · | $34 | $-125.3K | · | · | $-111.7K | $-64.9K | |
| Net Income | $-178M | $-88M | $-40M | $-113M | $-27M | $-11M | $-18M | $-6M | $-2M | |
| EPS (Basic) | $-1.08 | $-0.91 | $-0.71 | $-2.16 | · | · | · | · | · | |
| EPS (Diluted) | $-1.08 | $-0.91 | $-0.71 | $-2.16 | · | · | · | · | · | |
| Shares (Basic) | 165,061,967 | 97,511,557 | 56,265,362 | 52,528,024 | · | · | · | · | · | |
| Shares (Diluted) | 165,061,967 | 97,511,557 | 56,265,362 | 52,528,024 | · | · | · | · | · | |
| EBITDA | $-189M | $-82M | · | $-116M | · | · | · | · | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $92.7K | $220.5K | $2M | $9M | $21M | $9M | $12M | $16M | $4M | |
| Prepaid Expense | · | $668.9K | · | $393.0K | $232.9K | $242.9K | $192.0K | $38.3K | $33.4K | |
| Current Assets | $1M | $2M | $3M | $10M | $21M | $9M | $12M | $16M | $4M | |
| PP&E (Net) | $367.8K | $482.1K | $509.0K | $586.5K | $719.4K | $778.1K | $687.5K | $27.4K | · | |
| PP&E (Gross) | $1M | $1M | $973.8K | $944.0K | $980.0K | $931.1K | $746.7K | $261.2K | $226.4K | |
| Accum. Depreciation | $702.2K | $578.3K | $464.8K | $357.5K | $260.7K | $153.0K | $59.2K | $233.8K | $226.4K | |
| Goodwill | $6M | $159M | $12M | $12M | $12M | $12M | $12M | $12M | · | |
| Intangibles | $166.0K | $30.0K | $39.7K | $44.3K | $65.9K | $77.3K | $93.3K | $111.5K | $124.4K | |
| Other Non-current Assets | $7M | $161M | $55M | $74M | $168M | $168M | · | · | · | |
| Total Assets | $8M | $163M | $58M | $85M | $190M | $178M | $180M | $183M | $5M | |
| Accrued Liabilities | $6M | $5M | $723.2K | $1M | $1M | $470.6K | $336.9K | $66.9K | $229.6K | |
| Short-term Debt | · | · | $5M | · | · | · | · | · | · | |
| Current Liabilities | $29M | $30M | $11M | $6M | $2M | $1M | $1M | $873.7K | $3M | |
| Capital Leases | $424.5K | $842.4K | $775.6K | $985.7K | $1M | $2M | · | · | · | |
| Other Non-current Liabilities | $271.6K | $231.4K | $184.7K | $166.6K | · | · | · | · | · | |
| Total Liabilities | $30M | $31M | $12M | $12M | $15M | $12M | $7M | $24M | $3M | |
| Common Stock | $1.8K | $15.8K | $6.4K | $5.3K | $5.2K | $4.7K | $4.5K | $3.6K | $1.2K | |
| Paid-in Capital | $478M | $465M | $291M | $277M | $266M | $230M | $226M | $193M | $30M | |
| Retained Earnings | $-510M | $-332M | $-244M | $-204M | $-91M | $-64M | $-53M | $-35M | $-28M | |
| AOCI | $11M | $-170.8K | $-29.9K | $-30.4K | $-10.8K | $-41.4K | $101.8K | $205.7K | $352.8K | |
| Stockholders' Equity | $-21M | $132M | $47M | $73M | $175M | $166M | $173M | $159M | $2M | |
| Liabilities + Equity | $8M | $163M | $58M | $85M | $190M | $178M | $180M | $183M | $5M | |
| Shares Outstanding | 17,739,291 | 158,452,644 | 63,698,144 | 53,007,082 | 52,219,661 | 46,497,409 | 45,273,924 | 36,163,924 | 12,433,290 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $129.1K | $121.9K | $113.5K | $123.6K | $123.5K | $108.6K | $71.7K | $18.5K | $14.5K | |
| Stock-based Comp | $3M | $5M | $4M | $5M | $1M | $884.7K | $2M | $63.7K | · | |
| Deferred Tax | $0 | $0 | $0 | · | · | · | · | · | · | |
| Amort. of Intangibles | $9.9K | $8.3K | $6.2K | $15.0K | $15.9K | $14.8K | $15.2K | $18.5K | $19.8K | |
| Other Non-cash | $167M | $73M | · | $92M | · | · | · | · | · | |
| Operating Cash Flow | $-8M | $-11M | $-12M | $-16M | $-21M | $-10M | $-9M | $-4M | $-1M | |
| CapEx | · | $70.4K | $29.8K | $5.2K | $48.9K | $184.5K | $716.7K | $30.0K | · | |
| Investing Cash Flow | $-500.0K | $-1M | $-29.8K | $-5.2K | $-48.9K | $-184.5K | $-716.7K | $-575.7K | $-196.1K | |
| Stock Issued | · | · | · | · | $74.1K | · | · | $17M | $4M | |
| Financing Cash Flow | $8M | $11M | $5M | $4M | $33M | $7M | $6M | $17M | $6M | |
| Net Change in Cash | $-127.8K | $-2M | $-7M | $-11M | $12M | $-4M | $-3M | $12M | $4M | |
| Taxes Paid | $0 | $0 | $0 | $34 | $37 | · | · | · | $64.0K | |
| Free Cash Flow | · | $-11M | · | $-16M | · | · | · | · | · | |
| Levered FCF | · | · | · | $-16M | · | · | · | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -207.8% | · | · | -82.7% | · | · | · | · | · | |
| ROE | -586.4% | · | · | -97.0% | · | · | · | · | · | |
| ROIC | · | · | · | -159.8% | · | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.0 | · | · | 1.5 | · | · | · | · | · | |
| Quick Ratio | 0.0 | · | · | 1.4 | · | · | · | · | · | |
| Interest Coverage | · | · | · | -311.3 | · | · | · | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.12 | · | · | $1.37 | · | · | · | · | · | |
| Cash Flow / Share | $-0.05 | $-0.11 | · | · | · | · | · | · | · | |
| Cash / Share | $0.00 | · | · | $0.17 | · | · | · | · | · | |
| EPS (TTM) | $-1.08 | $-0.91 | $-0.71 | $-2.16 | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-178M | $-88M | $-40M | $-113M | $-27M | $-11M | $-18M | $-6M | $-2M | |
| Market Cap | $513M | · | · | $1.02B | · | · | · | · | · | |
| P/E | -2.7 | -19.2 | -8.0 | -8.9 | · | · | · | · | · | |
| P/B | -24.0 | · | · | 14.1 | · | · | · | · | · | |
| P / Tangible Book | · | · | 10.4 | 16.8 | 15.9 | 12.7 | · | · | · | |
| P / Cash Flow | -65.1 | · | · | -65.0 | · | · | · | · | · | |
| P / FCF | · | · | · | -65.0 | · | · | · | · | · | |
| Earnings Yield | -37.4% | -5.2% | -12.5% | -11.2% | · | · | · | · | · |
Income Statement
| Metric | Trend | Q3 2026 |
|---|---|---|
| Revenue | $20.9K | |
| Gross Profit | $20.9K | |
| R&D Expense | $15.9K | |
| SG&A Expense | $1M | |
| Operating Expenses | $1M | |
| Operating Income | $-1M | |
| Other Non-op | $-1M | |
| Net Income | $-3M | |
| EPS (Basic) | $-0.10 | |
| EPS (Diluted) | $-0.10 | |
| Shares (Basic) | 24,994,200 | |
| Shares (Diluted) | 24,994,200 |
Balance Sheet
| Metric | Trend | Q3 2026 |
|---|---|---|
| Cash & Equivalents | $3M | |
| Current Assets | $4M | |
| PP&E (Net) | $13.0K | |
| Goodwill | $6M | |
| Intangibles | $119.1K | |
| Other Non-current Assets | $6M | |
| Total Assets | $10M | |
| Accrued Liabilities | $5M | |
| Current Liabilities | $19M | |
| Capital Leases | $131.3K | |
| Total Liabilities | $19M | |
| Common Stock | $3.6K | |
| Paid-in Capital | $503M | |
| Retained Earnings | $-512M | |
| AOCI | $-155.7K | |
| Stockholders' Equity | $-10M | |
| Liabilities + Equity | $10M | |
| Shares Outstanding | 35,772,800 |
Cash Flow
| Metric | Trend | Q3 2026 |
|---|---|---|
| D&A | $11.0K | |
| Stock-based Comp | $169.0K | |
| Operating Cash Flow | $-1M | |
| CapEx | $0 | |
| Investing Cash Flow | $0 | |
| Financing Cash Flow | $4M | |
| Net Change in Cash | $3M |
Per Share
| Metric | Trend | Q3 2026 |
|---|---|---|
| EPS (TTM) | $-0.05 |
Valuation (TTM)
| Metric | Trend | Q3 2026 |
|---|---|---|
| Net Income TTM | $-1M | |
| P/E | -8.2 | |
| Earnings Yield | 509.8% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Net Income | $-178M | $-88M | $-40M | $-113M | $-27M |
| Diluted EPS | $-1.08 | $-0.91 | $-0.71 | $-2.16 | · |
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Current Ratio | 0.0 | · | · | 1.5 | · |
| Quick Ratio | 0.0 | · | · | 1.4 | · |
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Free Cash Flow | · | $-11M | · | $-16M | · |
Institutional owners (13F) 1 filer · $438K total · As of Dec. 31, 2025
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
1
Value held
$438K
New positions
10
Exited positions
4
Institutional activity — Q1 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 10 (+2 vs prior Q) | 4 (-1 vs prior Q) | 5 (0 vs prior Q) | 4 (-3 vs prior Q) | -125K |
Compared to Q4 2025. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $438,364 | 497,011 | 100.00% | Shares |
Activists & 5%+ owners 6 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| William Anderson Wittekind ×15 filings | Dec. 9, 2025 | 6.80% | Amendment | · | SEC |
| Rene Sindlev, RS Bio ApS ×7 filings | Feb. 16, 2024 | · | Initial filing | · | SEC |
| RS Group ApS, Rene Sindlev, RS Arving ApS ×4 filings | Jan. 24, 2024 | · | Initial filing | · | SEC |
| Weird Science LLC, William Anderson Wittekind ×10 filings | May 19, 2023 | · | Initial filing | · | SEC |
| Karsten Ree Holding B ApS IRS Identification Number : N/A | March 5, 2015 | · | Initial filing | Passive investment | SEC |
| RS Group ApS IRS Identification Number: N/A | March 5, 2015 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 29 insiders · 6 officers · 18 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| David Hershel Weinstein | Chief Executive Officer | Oct. 14, 2024 A | 250,000 | 0 | 0 | $0 |
| Mark Dybul | Chief Executive Officer | Feb. 13, 2024 A | 66,196 | 0 | 0 | $0 |
| Nathen Fuentes | Chief Financial Officer | Jan. 21, 2025 A | · | 0 | 0 | $0 |
| Simon Tarsh | Interim CFO | Nov. 4, 2024 A | · | 0 | 0 | $0 |
| Luisa Puche | Chief Financial Officer | Feb. 13, 2024 A | 16,266 | 0 | 0 | $0 |
| Francois Binette | COO and Executive VP for R&D | Feb. 13, 2024 A | · | 0 | 0 | $0 |
| Maurice Van Tilburg | Director | Jan. 21, 2025 A | 250,000 | 0 | 0 | $0 |
| Mark Anthony Collins | Director | Nov. 4, 2024 A | · | 0 | 0 | $0 |
| Douglas W Calder | Director | Nov. 4, 2024 A | · | 0 | 0 | $0 |
| James A Mcnulty | Director | Nov. 4, 2024 A | · | 0 | 0 | $0 |
| Avram Miller | Director | Aug. 23, 2024 A | 166,667 | 0 | 0 | $0 |
| Karen Brink | Director | Aug. 12, 2024 J | 25,372,969 | 0 | 0 | $0 |
| Ruud Hendriks | Director | June 25, 2024 A | · | 0 | 0 | $0 |
| Jayne Mcnicol | Director | June 25, 2024 A | · | 0 | 0 | $0 |
| Rene Sindlev | Director | June 25, 2024 A | 13,605,297 | 0 | 0 | $0 |
| Carol L Brosgart | Director | June 25, 2024 A | · | 0 | 0 | $0 |
| James Sapirstein | Director | June 25, 2024 A | · | 0 | 0 | $0 |
| Gregg H Alton | Director | June 25, 2024 A | · | 0 | 0 | $0 |
| Henrik Gronfeldt-Sorensen | Director | Oct. 9, 2023 A | 50,000 | 0 | 0 | $0 |
| Leni Boeren | Director | Oct. 4, 2023 A | · | 0 | 0 | $0 |
| An Evelyn D | Director | March 6, 2021 A | · | 0 | 0 | $0 |
| Niels Erik Nielsen, | Director | Sept. 20, 2016 A | · | 0 | 0 | $0 |
| William Anderson Wittekind | 10% owner | March 10, 2025 J | 3,353,878 | 0 | 0 | $0 |
| Ole Abildgaard | 10% owner | Feb. 13, 2024 C | 6,898,482 | 0 | 0 | $0 |
| Weird Science LLC | 10% owner | Oct. 13, 2022 J | 1,313,499 | 0 | 0 | $0 |
| Serhat Gumrukcu | 10% owner | May 18, 2022 S | 12,273,059 | 0 | 0 | $0 |
| Carl Forest Sandler | · | April 15, 2022 J | 4,449,104 | 0 | 0 | $0 |
| Eric Jean Marie Leire, | · | May 24, 2018 P | 73,246 | 0 | 0 | $0 |
| Aldo Petersen | · | Sept. 20, 2016 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 1 ETF
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0.00% | 16,081 SH | Aug. 19, 2026 | Daily |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed May 15, 2026